Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Comparative evaluation of incretin‐based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure†. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.regpep.2004.07.014
10.1016/j.regpep.2004.07.014 · External reference
10.1016/j.beem.2009.03.002
10.1016/j.beem.2009.03.002 · External reference
10.1111/j.1463-1326.2007.00765.x
10.1111/j.1463-1326.2007.00765.x · External reference
10.1053/j.gastro.2007.03.054
10.1053/j.gastro.2007.03.054 · External reference
10.1016/s0140-6736(06)69705-5
10.1016/s0140-6736(06)69705-5 · External reference
10.2337/diacare.27.11.2628
10.2337/diacare.27.11.2628 · External reference
10.2337/diacare.28.5.1092
10.2337/diacare.28.5.1092 · External reference
10.2337/diacare.28.5.1083
10.2337/diacare.28.5.1083 · External reference
10.2337/dc06-0706
10.2337/dc06-0706 · External reference
10.1111/j.1463-1326.2006.00704.x
10.1111/j.1463-1326.2006.00704.x · External reference
10.1111/j.1464-5491.2007.02191.x
10.1111/j.1464-5491.2007.02191.x · External reference
10.1111/j.1463-1326.2008.00994.x
10.1111/j.1463-1326.2008.00994.x · External reference
10.2337/dc08-1984
10.2337/dc08-1984 · External reference
10.2741/2799
10.2741/2799 · External reference
10.1016/s0140-6736(08)61246-5
10.1016/s0140-6736(08)61246-5 · External reference
10.1111/j.1464-5491.2009.02666.x
10.1111/j.1464-5491.2009.02666.x · External reference
10.2337/dc08-1355
10.2337/dc08-1355 · External reference
10.1007/s00125-009-1472-y
10.1007/s00125-009-1472-y · External reference
10.1016/s0140-6736(09)60659-0
10.1016/s0140-6736(09)60659-0 · External reference
10.2337/dc06-2375
10.2337/dc06-2375 · External reference
10.1016/s0140-6736(08)61206-4
10.1016/s0140-6736(08)61206-4 · External reference
10.2337/dc08-1961
10.2337/dc08-1961 · External reference
Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without increasing weight gain or hypoglycemia (abstract)
2008 · External reference
10.1111/j.1742-1241.2008.01933.x
10.1111/j.1742-1241.2008.01933.x · External reference
10.1111/j.1463-1326.2008.00876.x
10.1111/j.1463-1326.2008.00876.x · External reference
10.1016/j.amjmed.2009.03.012
10.1016/j.amjmed.2009.03.012 · External reference
10.1016/s0140-6736(87)91194-9
10.1016/s0140-6736(87)91194-9 · External reference
10.1210/jcem.87.3.8355
10.1210/jcem.87.3.8355 · External reference
10.1007/s00125-006-0433-y
10.1007/s00125-006-0433-y · External reference
No impairment of hypoglycemia counterregulation via glucagon with NN2211, a GLP‐1 derivative, in subjects with type 2 diabetes (abstract 550‐P)
2003 · External reference
10.2337/diabetes.53.9.2397
10.2337/diabetes.53.9.2397 · External reference
10.1210/endo.130.1.1309325
10.1210/endo.130.1.1309325 · External reference
10.1210/en.2003-0323
10.1210/en.2003-0323 · External reference
10.1172/jci116186
10.1172/jci116186 · External reference
10.1038/379069a0
10.1038/379069a0 · External reference
10.1152/ajpregu.1999.276.5.r1541
10.1152/ajpregu.1999.276.5.r1541 · External reference
10.1172/jci990
10.1172/jci990 · External reference
10.1016/s0140-6736(02)07952-7
10.1016/s0140-6736(02)07952-7 · External reference
10.2337/diabetes.50.4.785
10.2337/diabetes.50.4.785 · External reference
10.2337/diabetes.48.12.2270
10.2337/diabetes.48.12.2270 · External reference
10.1210/endo.143.8.8973
10.1210/endo.143.8.8973 · External reference
10.1038/sj.bjp.0705397
10.1038/sj.bjp.0705397 · External reference
10.1210/en.2002-220897
10.1210/en.2002-220897 · External reference
10.1210/en.2002-220405
10.1210/en.2002-220405 · External reference
10.2337/db05-1602
10.2337/db05-1602 · External reference
The DPP‐4 inhibitor vildagliptin increases pancreatic beta cell mass in rodents (abstract 481)
2005 · External reference
10.2337/dc08-1797
10.2337/dc08-1797 · External reference
10.1056/nejmoa066224
10.1056/nejmoa066224 · External reference
10.1016/s0140-6736(98)07019-6
10.1016/s0140-6736(98)07019-6 · External reference
10.1056/nejmoa0806470
10.1056/nejmoa0806470 · External reference
Unresolved reference
2008 · External reference
10.1007/s00125-006-0316-2
10.1007/s00125-006-0316-2 · External reference
10.1056/nejmp068294
10.1056/nejmp068294 · External reference
10.1007/s00125-008-1157-y
10.1007/s00125-008-1157-y · External reference
10.7326/0003-4819-143-8-200510180-00006
10.7326/0003-4819-143-8-200510180-00006 · External reference
10.1007/s00125-006-0510-2
10.1007/s00125-006-0510-2 · External reference
10.1358/dof.2001.026.07.628723
10.1358/dof.2001.026.07.628723 · External reference
Dose range effects of the new once daily GLP‐1 receptor agonist AVE0010 added to metformin in type 2 diabetes (abstract)
2008 · External reference
A dose‐finding study of the new GLP‐1 agonists AVE0010 in type 2 diabetes insufficiently controlled with metformin (abstract)
2008 · External reference
Safety and efficacy of a once‐weekly, long‐acting release formulation of exenatide over 15 weeks in patients with type 2 diabetes (abstract 487‐P)
2006 · External reference
10.1016/s0928-0987(03)00073-3
10.1016/s0928-0987(03)00073-3 · External reference
10.1055/s-2006-924230
10.1055/s-2006-924230 · External reference
10.1002/dmrr.499
10.1002/dmrr.499 · External reference
10.2337/dc07-0627
10.2337/dc07-0627 · External reference
10.1046/j.1464-5491.2002.00774.x
10.1046/j.1464-5491.2002.00774.x · External reference
10.1016/j.diabres.2004.09.002
10.1016/j.diabres.2004.09.002 · External reference
10.1007/s00125-005-1751-1
10.1007/s00125-005-1751-1 · External reference
10.1185/030079906x104786
10.1185/030079906x104786 · External reference
10.1001/jama.283.13.1695
10.1001/jama.283.13.1695 · External reference
10.1111/j.1464-5491.2006.01800.x
10.1111/j.1464-5491.2006.01800.x · External reference
10.2337/diab.47.1.57
10.2337/diab.47.1.57 · External reference
10.1111/j.1463-1326.2006.00589.x
10.1111/j.1463-1326.2006.00589.x · External reference
10.1111/j.1463-1326.2007.00839.x
10.1111/j.1463-1326.2007.00839.x · External reference
10.1185/030079908x260925
10.1185/030079908x260925 · External reference
10.2337/dc06-1732
10.2337/dc06-1732 · External reference
10.2337/diacare.22.6.960
10.2337/diacare.22.6.960 · External reference
10.2337/diacare.21.12.2050
10.2337/diacare.21.12.2050 · External reference
10.7326/0003-4819-130-5-199903020-00002
10.7326/0003-4819-130-5-199903020-00002 · External reference
10.1007/s00125-005-0132-0
10.1007/s00125-005-0132-0 · External reference
10.1111/j.1463-1326.2007.00820.x
10.1111/j.1463-1326.2007.00820.x · External reference
10.1016/j.clinthera.2007.11.006
10.1016/j.clinthera.2007.11.006 · External reference
